Helicobacter pylori and gastroduodenal secretory function.
Pounder
R E
RE
D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D001639:Bicarbonates / Q000378:metabolism; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000209:etiology; D004386:Duodenum / Q000187:drug effects*; D005744:Gastric Acid / Q000378:metabolism; D005753:Gastric Mucosa / Q000378:metabolism*; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D016480:Helicobacter pylori; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D009853:Omeprazole / Q000627:therapeutic use; D013392:Sucralfate / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D001639:Bicarbonates; D013392:Sucralfate; D009853:Omeprazole